Patrick Plewman, an SVP at Quest Diagnostics (NYSE:DGX), sold 958 shares of the company’s stock for $196,227.14, reducing his stake by 5.7%. This transaction follows a previous sale of 5,662 shares for $1.16 million earlier in the month. The news comes after Quest Diagnostics reported stronger-than-expected quarterly earnings and revenue, approved a $1.0 billion share buyback, and increased its quarterly dividend.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Quest Diagnostics (NYSE:DGX) SVP Sells $196,227.14 in Stock
Patrick Plewman, an SVP at Quest Diagnostics (NYSE:DGX), sold 958 shares of the company’s stock for $196,227.14, reducing his stake by 5.7%. This transaction follows a previous sale of 5,662 shares for $1.16 million earlier in the month. The news comes after Quest Diagnostics reported stronger-than-expected quarterly earnings and revenue, approved a $1.0 billion share buyback, and increased its quarterly dividend.